Astellas leaders, including Phil Tennant, Senior Vice President, Oncology Business Unit, Pranob Bhattacharya, Executive Director, Global Development Project Leader, Oncology, and Shelley Shaw, Executive Director, Gastrointestinal Cancer Global Brand Lead, shed light on Astellas’ commitment to gastric cancer research and advocacy. Watch them discuss the unmet need in gastric cancer, the importance of biomarker research, and the need for more treatment options for patients affected by the disease.

Click to play

Phil Tennant, Senior Vice President, Oncology Business Unit, Astellas Pharma US, answers a series of questions about gastric cancer and Astellas’ ongoing research in this disease.

Click to play

Pranob Bhattacharya, Executive Director, Global Development Project Leader, Oncology, Astellas Pharma Global Development, answers a series of questions about the need for advancements in gastric cancer treatment and the use of biomarkers to help create more targeted approaches. He sheds light on the ways that Astellas has been prioritizing research with emerging biomarkers to potentially develop personalized cancer treatments.

Click to play

Shelley Shaw, Executive Director, Gastrointestinal Cancer Global Brand Lead, Astellas Pharma US, discusses her personal experience with cancer and her role in addressing the unmet needs in gastric cancer through advocacy efforts. Shelley shares more about the impact of hearing firsthand from patients and advocacy groups and the ways this helps to drive progress in gastric cancer.

Gastric Cancer Media Resources

Early stage gastric and GEJ cancer frequently shows no symptoms, or the symptoms overlap with other gastric related conditions, making it difficult to detect. Learn more about the risk factors, signs, and symptoms.

  

New research is emerging around novel biomarkers that can uncover previously unidentified subsets of gastric and GEJ cancer patients. Learn more about what biomarkers are, why they are being explored and how they are being applied in the clinical landscape.

Back to the Gastric Cancer Hub Landing Page Back to the Astellas US Newsroom

074-0593-PM 11/22 MAT-US-NON-2022-01013

Follow Us On Social Media